{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:45:08Z","timestamp":1792424708941,"version":"4.5.0"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40620-015-0219-8","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T04:35:15Z","timestamp":1437539715000},"page":"659-668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Renal cancer in kidney transplanted patients"],"prefix":"10.1093","volume":"28","author":[{"given":"Giovanni M.","family":"Frasc\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Sandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cosmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Asch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Salviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"D\u2019Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Malvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Balestra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Gallieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"issue":"6","key":"219_CR1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/1055-9965.EPI-06-0078","volume":"15","author":"CM Vajdic","year":"2006","unstructured":"Vajdic CM, Grulich AE, Kaldor JM et al (2006) Specific infections, infection-related behavior, and risk of non-Hodgkin lymphoma in adults. Cancer Epidemiol Biomark Prev 15(6):1102\u20131108","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"219_CR2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.12659\/AOT.890908","volume":"19","author":"X Tillou","year":"2014","unstructured":"Tillou X, Chahwan C, Le Gal S, Bensadoun H, Doerfler A (2014) Prostatectomy for localized prostate cancer to prepare for renal transplantation in end-stage renal disease patients. Ann Transplant 19:569\u2013575","journal-title":"Ann Transplant"},{"issue":"2","key":"219_CR3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejca.2012.09.013","volume":"49","author":"P Piselli","year":"2012","unstructured":"Piselli P, Serraino D, Segoloni GP et al (2012) Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997\u20132009. Eur J Cancer 49(2):336\u2013344","journal-title":"Eur J Cancer"},{"issue":"2","key":"219_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.canep.2010.07.002","volume":"35","author":"HC Wisgerhof","year":"2011","unstructured":"Wisgerhof HC, van der Geest LG, de Fijter JW et al (2011) Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center. Cancer Epidemiol 35(2):105\u2013111","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"219_CR5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ki.2013.458","volume":"85","author":"D Farrugia","year":"2014","unstructured":"Farrugia D, Mahboob S, Cheshire J et al (2014) Malignancy-related mortality following kidney transplantation is common. Kidney Int 85(6):1395\u20131403","journal-title":"Kidney Int"},{"key":"219_CR6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1464-410X.2010.09856.x","volume":"108","author":"I Tsaur","year":"2010","unstructured":"Tsaur I, Oberm\u00fcller N, Jonas D et al (2010) De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients. BJUI 108:229\u2013234","journal-title":"BJUI"},{"issue":"2","key":"219_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1464-410X.2011.10315.x","volume":"109","author":"G Ploussard","year":"2012","unstructured":"Ploussard G, Chambade D, Meria P et al (2012) Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: a single-centre management experience in a 2396 recipient cohort. BJU Int 109(2):195\u2013199","journal-title":"BJU Int"},{"key":"219_CR8","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-137-00721-6","volume-title":"Policing the crisis: mugging, the state and law and order","author":"S Hall","year":"2013","unstructured":"Hall S, Critcher C, Jefferson T, Clarke J, Roberts B (2013) Policing the crisis: mugging, the state and law and order, 2nd edn. Palgrave Macmillan, Basingstoke","edition":"2"},{"key":"219_CR9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59\u201367","journal-title":"Lancet"},{"issue":"24","key":"219_CR10","first-page":"32","volume":"146","author":"M Guba","year":"2004","unstructured":"Guba M, L\u00f6he F (2004) Transplantation in cancer disease, and tumors in organ transplantation: current aspects and future prospects. MMW Fortschr Med 146(24):32\u201334","journal-title":"MMW Fortschr Med"},{"issue":"1","key":"219_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1600-6135.2003.00274.x","volume":"4","author":"RT Bustami","year":"2004","unstructured":"Bustami RT, Ojo AO, Wolfe RA, Merion RM, Bennett WM, McDiarmid SV, Leichtman AB, Held PJ, Port FK (2004) Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 4(1):87\u201393","journal-title":"Am J Transplant"},{"issue":"5","key":"219_CR12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1681\/ASN.2009101043","volume":"21","author":"MP Gallagher","year":"2010","unstructured":"Gallagher MP, Kelly PJ, Jardine M et al (2010) Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol 21(5):852\u2013858","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"219_CR13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","volume":"10","author":"R Salgo","year":"2010","unstructured":"Salgo R, Gossmann J, Sch\u00f6fer H et al (2010) Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of pre-malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial. Am J Transplant 10(6):1385\u20131393","journal-title":"Am J Transplant"},{"issue":"4","key":"219_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","volume":"367","author":"S Euvrard","year":"2012","unstructured":"Euvrard S, Morelon E, Rostaing L et al (2012) Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 367(4):329\u2013339","journal-title":"N Engl J Med"},{"key":"219_CR15","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","volume":"12","author":"SB Campbell","year":"2012","unstructured":"Campbell SB, Walker R, See Tai S, Jiang Q, Russ GR (2012) Randomized controlled trial of sirolimus for renal transplant. Am J Transpl 12:1146\u20131156","journal-title":"Am J Transpl"},{"key":"219_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ki.2013.538","volume":"86","author":"CM Hope","year":"2014","unstructured":"Hope CM, Grace BS, Pilkington KR et al (2014) The immune phenotype may relate to cancer development in kidney transplant recipients. Kidney Int 86:175\u2013183","journal-title":"Kidney Int"},{"issue":"10","key":"219_CR17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","volume":"31","author":"JM Hoogendijk-van den Akker","year":"2013","unstructured":"Hoogendijk-van den Akker JM, Harden PN, Hoitsma AJ et al (2013) Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus. J Clin Oncol 31(10):1317\u20131323","journal-title":"J Clin Oncol"},{"issue":"5","key":"219_CR18","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1053\/j.ajkd.2012.12.007","volume":"61","author":"RP Carroll","year":"2013","unstructured":"Carroll RP, Chapman JR (2013) Can the risk of skin cancer after transplantation be reduced by mTOR inhibitors? Am J Kidney Dis 61(5):698\u2013700","journal-title":"Am J Kidney Dis"},{"key":"219_CR19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C","volume":"45","author":"M Roederer","year":"2001","unstructured":"Roederer M (2001) Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45:194\u2013205","journal-title":"Cytometry"},{"issue":"8","key":"219_CR20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.TP.0000442773.38510.32","volume":"97","author":"MK Ma","year":"2014","unstructured":"Ma MK, Lim WH, Turner RM, Chapman JR, Craig JC, Wong G (2014) The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis. Transplantation 97(8):817\u2013825","journal-title":"Transplantation"},{"issue":"1","key":"219_CR21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.ASN.0000039608.81046.81","volume":"14","author":"JH Stewart","year":"2003","unstructured":"Stewart JH, Buccianti G, Agodoa L et al (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14(1):197\u2013207","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"219_CR22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1681\/ASN.2008090998","volume":"20","author":"G Wong","year":"2009","unstructured":"Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC (2009) Association of CKD and cancer risk in older people. J Am Soc Nephrol 20(6):1341\u20131350","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"219_CR23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/TP.0b013e31827743b4","volume":"95","author":"G Wong","year":"2013","unstructured":"Wong G, Turner RM, Chapman JR, Howell M, Lim WH, Webster AC, Craig JC (2013) Time on dialysis and cancer risk after kidney transplantation. Transplantation 95(1):114\u2013121","journal-title":"Transplantation"},{"issue":"1","key":"219_CR24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ki.1991.192","volume":"40","author":"JJ Grantham","year":"1991","unstructured":"Grantham JJ (1991) Acquired cystic kidney disease. Kidney Int 40(1):143\u2013152","journal-title":"Kidney Int"},{"issue":"6","key":"219_CR25","first-page":"671","volume":"11","author":"I Ishikawa","year":"1991","unstructured":"Ishikawa I (1991) Acquired cystic disease: mechanisms and manifestations. Semin Nephrol 11(6):671\u2013684","journal-title":"Semin Nephrol"},{"issue":"4","key":"219_CR26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00005792-199007000-00003","volume":"69","author":"MA Matson","year":"1990","unstructured":"Matson MA, Cohen EP (1990) Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore) 69(4):217\u2013226","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"219_CR27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/ki.1986.251","volume":"30","author":"N Narasimhan","year":"1986","unstructured":"Narasimhan N, Golper TA, Wolfson M, Rahatzad M, Bennett WM (1986) Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int 30(5):748\u2013752","journal-title":"Kidney Int"},{"issue":"2","key":"219_CR28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1067\/j.cpradiol.2013.12.002","volume":"43","author":"M Tonolini","year":"2014","unstructured":"Tonolini M, Rigiroli F, Villa F, Bianco R (2014) Complications of sporadic, hereditary, and acquired renal cysts: cross-sectional imaging findings. Curr Probl Diagn Radiol 43(2):80\u201390","journal-title":"Curr Probl Diagn Radiol"},{"issue":"Suppl 3","key":"219_CR29","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1111\/j.1542-4758.2007.00228.x","volume":"11","author":"AE Moore","year":"2007","unstructured":"Moore AE, Kujubu DA (2007) Spontaneous retroperitoneal hemorrhage due to acquired cystic kidney disease. Hemodial Int 11(Suppl 3):S38\u2013S40","journal-title":"Hemodial Int"},{"issue":"4","key":"219_CR30","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2215\/CJN.03661106","volume":"2","author":"A Schwarz","year":"2007","unstructured":"Schwarz A, Vatandaslar S, Merkel S, Haller H (2007) Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2(4):750\u2013756","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"219_CR31","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0022-5347(17)37523-7","volume":"147","author":"PS Chandhoke","year":"1992","unstructured":"Chandhoke PS, Albala DM, Clayman RV (1992) Long-term comparison of renal function in patients with solitary kidneys and\/or moderate renal insufficiency undergoing extracorporeal shock wave lithotripsy or percutaneous nephrolithotomy. J Urol 147(5):1226\u20131230","journal-title":"J Urol"},{"issue":"1","key":"219_CR32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00005392-199707000-00012","volume":"158","author":"JD Doublet","year":"1997","unstructured":"Doublet JD, Peraldi MN, Gattegno B, Thibault P, Sraer JD (1997) Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol 158(1):42\u201344","journal-title":"J Urol"},{"key":"219_CR33","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1600-6143.2011.03721.x","volume":"11","author":"BKP Goh","year":"2011","unstructured":"Goh BKP, Dean PG, Cosio FG, Gloor JM, Prieto M, Stegall MD (2011) Bilateral native ureteral ligation without nephrectomy in the management of kidney transplant recipients with native proteinuria. Am J Transplant 11:2747\u20132750","journal-title":"Am J Transplant"},{"issue":"10","key":"219_CR34","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1681\/ASN.2013101122","volume":"25","author":"JB Wetmore","year":"2014","unstructured":"Wetmore JB, Calvet JP, Yu AS, Lynch CF, Wang CJ, Kasiske BL, Engels EA (2014) Polycystic kidney disease and cancer after renal transplantation. J Am Soc Nephrol 25(10):2335\u20132341","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"219_CR35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","volume":"74","author":"P Hajj","year":"2009","unstructured":"Hajj P, Ferlicot S, Massoud W et al (2009) Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74(3):631\u2013634","journal-title":"Urology"},{"issue":"3","key":"219_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00125480-200305000-00003","volume":"10","author":"LD Truong","year":"2003","unstructured":"Truong LD, Choi YJ, Shen SS, Ayala G, Amato R, Krishnan B (2003) Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv Anat Pathol 10(3):135\u2013159","journal-title":"Adv Anat Pathol"},{"issue":"9","key":"219_CR37","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1681\/ASN.V491661","volume":"4","author":"DS Keith","year":"1994","unstructured":"Keith DS, Torres VE, King BF, Zincki H, Farrow GM (1994) Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 4(9):1661\u20131669","journal-title":"J Am Soc Nephrol"},{"key":"219_CR38","first-page":"11","volume":"1","author":"W Lane","year":"2011","unstructured":"Lane W, Lacefield E, Tran R, de Riese W (2011) The clinical association of autosomal dominant polycystic kidney disease and renal cell carcinoma. J Urol 1:11\u201314","journal-title":"J Urol"},{"issue":"1\u20132","key":"219_CR39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000351049","volume":"123","author":"CA Jilg","year":"2013","unstructured":"Jilg CA, Drendel V, Bacher J et al (2013) Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens. Nephron Clin Pract 123(1\u20132):13\u201321","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"219_CR40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","volume":"38","author":"RD Perrone","year":"2001","unstructured":"Perrone RD, Ruthazer R, Terrin NC (2001) Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis 38(4):777\u2013784","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"219_CR41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.1977.tb04076.x","volume":"49","author":"RJ Regan","year":"1977","unstructured":"Regan RJ, Abercrombie GF, Lee HA (1977) Polycystic renal disease\u2014occurrence of malignant change and role of nephrectomy in potential transplant recipients. Br J Urol 49(2):85\u201391","journal-title":"Br J Urol"},{"issue":"5","key":"219_CR42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0022-5347(17)55622-0","volume":"124","author":"RC Ng","year":"1980","unstructured":"Ng RC, Suki WN (1980) Renal cell carcinoma occurring in a polycystic kidney of a transplant recipient. J Urol 124(5):710\u2013712","journal-title":"J Urol"},{"issue":"7","key":"219_CR43","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/ndt\/12.7.1431","volume":"12","author":"H Hadimeri","year":"1997","unstructured":"Hadimeri H, Nord\u00e9n G, Friman S, Nyberg G (1997) Autosomal dominant polycystic kidney disease in a kidney transplant population. Nephrol Dial Transplant 12(7):1431\u20131436","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"219_CR44","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0041-1345(03)00619-5","volume":"35","author":"P Errasti","year":"2003","unstructured":"Errasti P, Manrique J, Lavilla J et al (2003) Autosomal-dominant polycystic kidney disease: high prevalence of graft loss for death-related malignancies and cardiovascular risk factors. Transplant Proc 35(5):1717\u20131719","journal-title":"Transplant Proc"},{"issue":"2","key":"219_CR45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0272-6386(03)00663-2","volume":"42","author":"MJ DeLong","year":"2003","unstructured":"DeLong MJ, Schmitt D, Scott KM, Ramakumar S, Lien YH (2003) Multicentric papillary renal carcinoma in renal allograft. Am J Kidney Dis 42(2):381\u2013384","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"219_CR46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","volume":"74","author":"P Hajj","year":"2009","unstructured":"Hajj P, Ferlicot S, Massoud W et al (2009) Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74(3):631\u2013634","journal-title":"Urology"},{"issue":"5","key":"219_CR47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1308\/003588411X582690","volume":"93","author":"P Patel","year":"2011","unstructured":"Patel P, Horsfield C, Compton F, Taylor J, Koffman G, Olsburgh J (2011) Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease. Ann R Coll Surg Engl 93(5):391\u2013395","journal-title":"Ann R Coll Surg Engl"},{"issue":"3","key":"219_CR48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-011-0950-8","volume":"129","author":"CJ Ward","year":"2011","unstructured":"Ward CJ, Wu Y, Johnson RA et al (2011) Germline PKHD1 mutations are protective against colorectal cancer. Hum Genet 129(3):345\u2013349","journal-title":"Hum Genet"},{"issue":"Suppl 15","key":"219_CR49","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.V11suppl_1s1","volume":"11","author":"BL Kasiske","year":"2000","unstructured":"Kasiske BL, Vazquez MA, Harmon WE et al (2000) Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 11(Suppl 15):S1\u2013S86","journal-title":"J Am Soc Nephrol"},{"key":"219_CR50","doi-asserted-by":"crossref","unstructured":"Renal Physicians Association\/American Society of Nephrology Working Group (2000) Clinical practice guidelines on shared decision-making in the appropriate initiation of and withdrawal from dialysis. J Am Soc Nephrol 11(7):1340\u20131342 (erratum: 11(9):2, following 1788)","DOI":"10.1681\/ASN.V1171340"},{"issue":"Suppl 3","key":"219_CR51","first-page":"S89","volume":"9","author":"BL Kasiske","year":"2009","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) Transplant Work Group, Kasiske BL, Zeier MG et al (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transpl 9(Suppl 3):S89\u2013S90","journal-title":"Am J Transpl"},{"issue":"3","key":"219_CR52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-2007-1015982","volume":"163","author":"G Heinz-Peer","year":"1995","unstructured":"Heinz-Peer G, Mostbeck GH, Banyai S, Helbich T, Turetschek K, Kainberger F (1995) Malignant neoplasms after kidney transplantation: value of an annual radiological screening program. Rofo 163(3):250\u2013255","journal-title":"Rofo"},{"issue":"2","key":"219_CR53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.eururo.2004.02.009","volume":"47","author":"T Kalbe","year":"2005","unstructured":"Kalbe T, Fulda G, Benoit M et al (2005) European Association of Urology guidelines on renal transplantation. Euro Urol 47(2):156\u2013166","journal-title":"Euro Urol"},{"issue":"5","key":"219_CR54","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/ndt\/gfq627","volume":"26","author":"G Wong","year":"2010","unstructured":"Wong G, Howard K, Webster AC, Chapman JR, Craig JC (2010) Screening for renal cancer in recipients of kidney transplants. Nephrol Dial Transpl 26(5):1729\u20131739","journal-title":"Nephrol Dial Transpl"},{"key":"219_CR55","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1600-6143.2011.03721.x","volume":"11","author":"BKP Goh","year":"2011","unstructured":"Goh BKP, Dean PG, Cosio FG, Gloor JM, Prieto M, Stegall MD (2011) Bilateral native ureteral ligation without nephrectomy in the management of kidney transplant recipients with native proteinuria. Am J Transpl 11:2747\u20132750","journal-title":"Am J Transpl"},{"key":"219_CR56","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.juro.2009.07.004","volume":"82","author":"SC Campbell","year":"2009","unstructured":"Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. Practice Guidelines Committee of the American Urological Association. J Urol 82:1271\u20131279","journal-title":"J Urol"},{"issue":"10","key":"219_CR57","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1464-410X.2011.10597.x","volume":"109","author":"GM Badalato","year":"2012","unstructured":"Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM (2012) Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach. BJU Int 109(10):1457\u20131462","journal-title":"BJU Int"},{"issue":"3","key":"219_CR58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.urology.2009.11.087","volume":"76","author":"CJ Weight","year":"2010","unstructured":"Weight CJ, Larson BT, Gao T et al (2010) Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. Urology 76(3):631\u2013637","journal-title":"Urology"},{"issue":"10","key":"219_CR59","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1111\/j.1600-6143.2011.03655.x","volume":"11","author":"JH Kaouk","year":"2011","unstructured":"Kaouk JH, Spana G, Hillyer SP, White MA, Haber GP, Goldfarb D (2011) Robotic-assisted laparoscopic partial nephrectomy for a 7-cm mass in a renal allograft. Am J Transpl 11(10):2242\u20132246","journal-title":"Am J Transpl"},{"issue":"3","key":"219_CR60","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.juro.2009.05.035","volume":"182","author":"A Kutikov","year":"2009","unstructured":"Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844\u2013853","journal-title":"J Urol"},{"issue":"5","key":"219_CR61","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.eururo.2009.07.040","volume":"56","author":"V Ficarra","year":"2009","unstructured":"Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56(5):786\u2013793","journal-title":"Eur Urol"},{"issue":"5","key":"219_CR62","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.juro.2010.01.005","volume":"183","author":"MN Simmons","year":"2010","unstructured":"Simmons MN, Ching CB, Samplaski MK, Park CH, Gill IS (2010) Kidney tumor location measurement using the C index method. J Urol 183(5):1708\u20131713","journal-title":"J Urol"},{"issue":"12","key":"219_CR63","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1089\/end.2011.0301","volume":"25","author":"Z Okhunov","year":"2011","unstructured":"Okhunov Z, Rais-Bahrami S, George AK et al (2011) The comparison of three renal tumor scoring systems: C-Index, P.A.D.U.A., and R.E.N.A.L. nephrometry scores. J Endourol 25(12):1921\u20131924","journal-title":"J Endourol"},{"issue":"1","key":"219_CR64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.juro.2011.03.020","volume":"186","author":"MN Hew","year":"2011","unstructured":"Hew MN, Baseskioglu B, Barwari K et al (2011) Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy. J Urol 186(1):42\u201346","journal-title":"J Urol"},{"issue":"5","key":"219_CR65","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1464-410X.2011.10452.x","volume":"109","author":"HM Rosevear","year":"2012","unstructured":"Rosevear HM, Gellhaus PT, Lightfoot AJ, Kresowik TP, Joudi FN, Tracy CR (2012) Utility of the RENAL nephrometry scoring system in the real world: predicting surgeon operative preference and complication risk. BJU Int 109(5):700\u2013705","journal-title":"BJU Int"},{"issue":"4","key":"219_CR66","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.eururo.2011.05.030","volume":"60","author":"J Simhan","year":"2011","unstructured":"Simhan J, Smaldone MC, Tsai KJ et al (2011) Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol 60(4):724\u2013730","journal-title":"Eur Urol"},{"key":"219_CR67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","volume":"4","author":"JB Brugarolas","year":"2003","unstructured":"Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG Jr (2003) TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4:147\u2013158","journal-title":"Cancer Cell"},{"key":"219_CR68","doi-asserted-by":"crossref","unstructured":"Escudier B, Porta C, Schmidinger M et al. ESMO Guidelines Working Group (2014). Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Sep 25(Suppl 3):iii49\u201356","DOI":"10.1093\/annonc\/mdu259"},{"key":"219_CR69","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2215\/CJN.08111109","volume":"5","author":"ES Robinson","year":"2010","unstructured":"Robinson ES, Matulonis UA, Ivy P, Berlin ST, Tyburski K, Penson RT, Humphreys BD (2010) Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitor. Clin J Am Soc Nephrol 5:477\u2013478","journal-title":"Clin J Am Soc Nephrol"},{"key":"219_CR70","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.amjmed.2008.11.025","volume":"122","author":"F Gurevich","year":"2009","unstructured":"Gurevich F, Perazella MA (2009) Renal effects of anti-angiogenesis therapy: update for the internist. Am J Med 122:322\u2013328","journal-title":"Am J Med"},{"key":"219_CR71","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.semnephrol.2010.09.006","volume":"30","author":"V Eremina","year":"2010","unstructured":"Eremina V, Quaggin SE (2010) Biology of anti-angiogenic therapy-induced thrombotic microangiopathy. Semin Nephrol 30:582\u2013590","journal-title":"Semin Nephrol"},{"key":"219_CR72","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(07)61904-7","volume":"370","author":"B Escudier","year":"2007","unstructured":"Escudier B, Pluzanska A, Koralewski P et al (2007) AVOREN Trial investigators. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Lancet 370:2103\u20132111","journal-title":"Lancet"},{"key":"219_CR73","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1470-2045(07)70285-1","volume":"8","author":"O Rixe","year":"2007","unstructured":"Rixe O, Bukowski RM, Michaelson MD et al (2007) Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study. Lancet Oncol 8:975\u2013984","journal-title":"Lancet Oncol"},{"key":"219_CR74","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J et al (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358:1129\u20131136","journal-title":"N Engl J Med"},{"key":"219_CR75","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/annonc\/mdt233","volume":"24","author":"H Izzedine","year":"2013","unstructured":"Izzedine H, Escudier B, Rouvier P, Gueutin V, Varga A, Bahleda R, Soria JC (2013) Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven. Ann Oncol 24:2421\u20132425","journal-title":"Ann Oncol"},{"key":"219_CR76","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","volume":"8","author":"M Guba","year":"2002","unstructured":"Guba M, von Breitenbuch P, Steinbauer M et al (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128\u2013135","journal-title":"Nat Med"},{"issue":"3","key":"219_CR77","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3182247ae2","volume":"92","author":"J Alber\u00fa","year":"2011","unstructured":"Alber\u00fa J, Pascoe MD, Campistol JM et al (2011) Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial. Transplantation 92(3):303\u2013310","journal-title":"Transplantation"},{"key":"219_CR78","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","volume":"87","author":"FP Schena","year":"2009","unstructured":"Schena FP, Pascoe MD, Alberu J et al (2009) Conversion from calcineurin inhibitors to Sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation 87:233\u2013242","journal-title":"Transplantation"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0219-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-015-0219-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0219-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:06Z","timestamp":1777564686000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/28\/6\/659\/8372269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1007\/s40620-015-0219-8","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]}}}